Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,024.00
Bid: 12,024.00
Ask: 12,028.00
Change: 36.00 (0.30%)
Spread: 4.00 (0.033%)
Open: 12,254.00
High: 12,256.00
Low: 12,018.00
Prev. Close: 11,988.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Thomas Cook Up As China's Fosun Takes Stake

Fri, 06th Mar 2015 11:37

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Friday.
-------
FTSE 100 WINNERS
-------
Weir Group, up 6% at 1,831.7 pence. The oil and gas service company's shares are rising on press reports about speculation that it could attract a bid from a US private equity firm. The Independent said that GE Capital is being linked with making a 2,800.00 pence per share bid, though it does attribute this to "starry-eyed punters".

ITV, up 1.2% at 244p. Liberum has raised the broadcaster's price target to 310p from 255p, keeping its Buy rating. The broadcaster shares have risen around 7% in the past week as several brokers have lifted price targets and recommendations. Goldman Thursday included the company in its "Conviction Buy List", with its price target at 284p from 253p, while JP Morgan raised its price target for the group to 251p from 243p, with a Overweight rating.
-------
FTSE 100 LOSERS
-------
Fresnillo, down 1.8%, Randgold Resources, down 1.5%. The gold miners are suffering from the weakness in precious metal prices, which have fallen over the last four days. Gold is down at USD1,196.85 Friday morning.

Anglo American, down 1.0%, and Rio Tinto, down 0.7%. Iron ore prices have fallen to a fresh six-year low of USD59.30 a tonne, according to reports. Rio also said Friday that it has increased its reserves in the Diavik diamond project, the Pilbara iron project and the Hail Creek Coal project.

AstraZeneca, down 1.0%. The pharmaceutical giant guided that it expects its total revenue to decline by a mid-single digit percentage at constant exchange rates in 2015, in line with previous sales revenue guidance it gave at the time of its full-year results. AstraZeneca said that based on current exchange rates, total revenue is expected to decline by low double-digit percent at actual exchange rates, and core earnings per share is expected to be broadly in line with 2014.
-------
FTSE 250 WINNERS
-------
Thomas Cook Group, up 19%. The travel operator said it has struck a strategic deal with Chinese investment group Fosun International under which the latter will acquire a 5% stake in Thomas Cook, or 73.1 million shares, for GBP91.8 million. The shares are valued at 125.58 pence, compared to the travel firm's closing price Thursday of 120.60p. Fosun, which recently bought France's Club Med, will also raise its stake to 10% by buying more shares in the open market. Shore Capital says the deal is a good one for Thomas Cook.

Afren, up 10%. The troubled oil and gas company, which will be relegated from the FTSE 250 on March 23, is looking to China to bring in "substantial" new capital in the form of new equity, the Financial Times reported. Ethelbert Cooper, the Liberian entrepreneur who founded Afren, plans to recapitalize the company in partnership with a consortium of Chinese investors. This will become the first Africa-China partnership in the oil and gas sector listed in the UK.
-------
FTSE 250 LOSERS
-------
Just Retirement Group, down 7% at 162.3p. Permira, the principal shareholder of Just Retirement Group, has sold around 50 million shares or a 10% stake in the company at a price of 162 pence per share through a secondary placing with institutional investors, raising GBP81 million for the private equity company. Permira had a 62.27% interest in the annuities provider, and that will fall to about 52%.
-------
AIM ALL-SHARE WINNERS
-------
Snoozebox Holdings, up 14%. The portable accommodation company confirmed media speculation that it has been selected to work on the Ealing Council tender for modular accommodation in London. Snoozebox said it, along with support services company Mears Group, has been selected to provide turnkey modular serviced accommodation as part of the Ealing Council tender for an immediate short-term housing solution.
-------
AIM ALL-SHARE LOSERS
-------
Daniel Stewart Securities, off 29%. The institutional stockbroker, wealth manager and corporate advisory's shares have been restored to trading following the publication of its restated results for 2014. The company got into difficulties last year after it identified a shortfall in regulatory capital, and its shares were suspended as it sought new funding to strengthen its balance sheet. The group in January said it has secured GBP1.5 million in new funding through two cash subscriptions and via a loan note agreement.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.